Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4058060 Title: INHIBITION DE L'INTERFÉRON DE TYPE I DANS LE LUPUS ÉRYTHÉMATEUX DISSÉMINÉ

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
208045310
WO application number:
EP2020081770
Type:
European patent granted for BE
Status:
Open
Publication number:
4058060
WO publication number:
WO2021094378
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
11/11/2020
Grant date:
19/02/2025
EP publication date:
21/09/2022
WO publication date:
20/05/2021
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
19/02/2025
EP B1 publication date:
19/02/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
11/11/2040

Applicant

Name:
Astrazeneca AB
Legal Form:
From:
19/02/2025
Address:
151 85 Södertälje, Sweden (SE)
To:

Agent

Name:
NOVAGRAAF BREVETS
Legal Form:
From:
11/03/2025
Address:
Bâtiment O2 2 rue Sarah Bernhardt CS90017, 92665, Asnières-sur-Seine Cedex, France (FR)
To:

Inventor

1

Name:
BERGLIND, Anna
Legal Form:
Address:
151 85 Södertälje, Sweden (SE)

2

Name:
ABREU, Gabriel
Legal Form:
Address:
151 85 Södertälje, Sweden (SE)

3

Name:
PINEDA, Lilia
Legal Form:
Address:
Wilmington, Delaware 19850, United States (US)

4

Name:
TUMMALA, Raj
Legal Form:
Address:
Wilmington, Delaware 19850, United States (US)

5

Name:
ASKANASE, Anca
Legal Form:
Address:
New York, NY 10032, United States (US)

6

Name:
RICHEZ, Christophe
Legal Form:
Address:
33076 Bordeaux, France (FR)

7

Name:
MORAND, Eric
Legal Form:
Address:
Clayton, Victoria 3168, Australia (AU)

8

Name:
BRUCE, Ian
Legal Form:
Address:
Manchester M13 9PT, United Kingdom (GB)

9

Name:
BROHAWN, Philip
Legal Form:
Address:
Cambridge Cambridgeshire CB2 0AA, United Kingdom (GB)

10

Name:
FURIE, Richard
Legal Form:
Address:
Hempstead, NY 11549, United States (US)

11

Name:
BAE, Sang-Cheol
Legal Form:
Address:
Seoul 04763, Korea (Republic) (KR)

12

Name:
TANAKA, Yoshiya
Legal Form:
Address:
Kitakyushu, 807-8555, Japan (JP)

13

Name:
WERTH, Victoria
Legal Form:
Address:
Philadelphia, Pennsylvania 19104, United States (US)

14

Name:
VOLLENHOVEN, Ronald Van
Legal Form:
Address:
1007 MB Amsterdam, Netherlands (NL)

15

Name:
ISENBERG, David
Legal Form:
Address:
London WC1E 6JF, United Kingdom (GB)

16

Name:
VITAL, Ed
Legal Form:
Address:
Leeds LS7 4SA, United Kingdom (GB)

17

Name:
KAHLENBERG, Michelle
Legal Form:
Address:
Ann Arbor, Michigan 48109-5422, United States (US)

18

Name:
KALYANI, Rubana
Legal Form:
Address:
Gaithersburg, Maryland 20878, United States (US)

19

Name:
KALUNIAN, Kenneth
Legal Form:
Address:
La Jolla, California 92037, United States (US)

Priority

1

Priority patent number:
202063089345 P
Priority date:
08/10/2020
Priority country:
United States (US)

2

Priority patent number:
202063031848 P
Priority date:
29/05/2020
Priority country:
United States (US)

3

Priority patent number:
201962933672 P
Priority date:
11/11/2019
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 39/395; A61P 37/00;

Publication

European Patent Bulletin

Issue number:
202508
Publication date:
19/02/2025
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
01/12/2025
Annual fee number:
6
Annual fee amount:
95 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
11/03/2025 Incoming Correspondence (Post) 1 PDF /3/3/8/0/1/0722510833/docs/208045310_0_incomingcorrespondencepaper_20250311_090655417.pdf